W(C
MES)(CO)(Cl)L 2 L'(L = P(OMe)3,L'= CO(2a); L = PMe 3,L'= CO(2b); L = P(O iPr)3,L'=
吡啶(py)(2c); L PPh 3,L'= CO(2d);2L = Ph 2 PCH 2 CH 2 PPh 2,L'= CO(2e)),W(C
MES)(CO)(Cl)L 3(L = P(OMe)3(3a); L = PMe 3(3b)); 3L = Ph 2 PCH 2 CH 2)2 PPh(3d))和W(C
MES)(Cl)L 4(L = P(OMe)3(4a))已从W(C
MES)开始制备(CO)2(Cl)(py)2(1)。用NaBH
氯化物配合物的治疗4在THF中提供的
硼氢化加合物W(η 2 -H 2 BH 2)(C
MES)(CO)L- 2(L = P(OME)3(图5a); L = PME 3(图5b); L = P(O